Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia.

@article{Andrews1999ImplantableDE,
  title={Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia.},
  author={Norman P. Andrews and Richard Ira Fogel and Gemma Pelargonio and Juanita J. Evans and Eric N Prystowsky},
  journal={Journal of the American College of Cardiology},
  year={1999},
  volume={34 7},
  pages={
          2023-30
        }
}
OBJECTIVES To assess the clinical significance of inducible ventricular tachyarrhythmias among patients with unexplained syncope. BACKGROUND Induction of sustained ventricular arrhythmias at electrophysiology study in patients with unexplained syncope and structural heart disease is usually assigned diagnostic significance. However, the true frequency of subsequent spontaneous ventricular tachyarrhythmias in the absence of antiarrhythmic medications is unknown. METHODS In a retrospective… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

Sudden death risk in syncope: the role of the implantable cardioverter defibrillator.

VIEW 1 EXCERPT
CITES BACKGROUND

Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011).

Guidelines for the diagnosis and management of syncope (version 2009).

VIEW 1 EXCERPT
CITES METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES